Cresco LabsFRA:6CQ -8.86%43 Days Inventory is 123.78 as of Mar. 2026, which is 21% above its 10-year median of 102.11. GuruFocus rates FRA:6CQ with a GF Score™ of 43/100 and a GF Value™ of €0.78 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 923 Drug Manufacturers companies, Cresco Labs ranks better than 75.3% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Cresco Labs's Average Total Inventories for the
three
months ended in Mar. 2026 was €89.0 Mil. Cresco Labs's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €65.6 Mil.
Hence, Cresco Labs's Days Inventory for the
three
months ended in Mar. 2026 was 123.78.
The historical rank and industry rank for Cresco Labs's Days Inventory or its related term are showing as below:
FRA:6CQ'
s Days Inventory Range Over the Past 10 Years
Min: 89.58 Med: 102.11 Max: 460.67
Current: 109.43
During the past 13 years, Cresco Labs's highest Days Inventory was 460.67. The lowest was 89.58. And the median was 102.11.
FRA:6CQ's Days Inventory is ranked better than 75.3% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs FRA:6CQ: 109.43
Cresco Labs's Days Inventory
increased
from Mar. 2025 (90.56) to Mar. 2026 (123.78).
It might indicate that Cresco Labs's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cresco Labs's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.74.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cresco Labs's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.68.
Cresco Labs (FRA:6CQ) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cresco Labs's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cresco Labs's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Cresco Labs Days Inventory Related Terms
Cresco Labs Days Inventory Historical Data
* Premium members only.
The historical data trend for Cresco Labs's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cresco Labs Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Days Inventory distribution charts can be found below:
* The bar in red indicates where Cresco Labs's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cresco Labs (FRA:6CQ) has a Days Inventory of 123.78 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cresco Labs and its competitors. This is 21% above median its historical median of 102.11. Over the past decade, Cresco Labs' Days Inventory has ranged from 89.58 to 460.67. According to the industry distribution chart, Cresco Labs ranks #228 out of 923 companies in the Drug Manufacturers industry, placing it in the top 24.7%.
Is Cresco Labs' Days Inventory too high?
Cresco Labs' current Days Inventory of 123.78 is 21% above median its 10-year median of 102.11. Over the past 10 years, this metric has ranged from a low of 89.58 to a high of 460.67. The Drug Manufacturers industry median Days Inventory is 164.48. Cresco Labs' value of 123.78 is 24.7% below this industry median. Based on the distribution chart, Cresco Labs ranks #228 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Cresco Labs has a GF Score™ of 43/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cresco Labs' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cresco Labs ranks #228 out of 923 companies for Days Inventory. This places Cresco Labs in the top 25% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.48. Cresco Labs' value of 123.78 is 24.7% below this benchmark. Historically, Cresco Labs' own Days Inventory has ranged from 89.58 to 460.67 over the past decade. While the company's 10-year median is 102.11 vs. the industry median of 164.48, Cresco Labs has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cresco Labs's current Days Inventory of 123.78 is 24.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cresco Labs and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cresco Labs's current Days Inventory is 123.78, which is 21% above median its own 10-year median of 102.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cresco Labs stock overvalued right now?
Based on GuruFocus' analysis, Cresco Labs (FRA:6CQ) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.78, compared to a current price of €0.64 — trading 18.2% below its estimated fair value. The current Days Inventory is 123.78, which is 21% above median its 10-year median of 102.11 and 24.7% below the Drug Manufacturers industry median of 164.48. Cresco Labs' overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Cresco Labs (FRA:6CQ), the current Days Inventory is 123.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cresco Labs (FRA:6CQ) Overvalued in 2026?
Based on GuruFocus' analysis, Cresco Labs stock appears to be undervalued.
The current stock price of €0.64 is trading 18.2% below its estimated GF Value™ of €0.78.
GuruFocus considers Cresco Labs to be Modestly Undervalued.
Key valuation signals for FRA:6CQ:
Days Inventory: 123.78 (21% above median its 10-year median of 102.11)
GF Value™: €0.78 vs. price of €0.64 (18.2% below fair value)
Industry Position: 24.7% below the Drug Manufacturers median (#228 of 923)
No single metric tells the full story. See the FRA:6CQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.
43GF Score
Get the complete analysis for FRA:6CQ
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:6CQ has been successfully added to your 
